Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

ROLE OF DUAL-TASK COST IN PREDICTING FALL RISK AMONG OLDER ADULTS RECEIVING INSTITUTIONAL CARE

3 giugno 2026 aggiornato da: MİNE PEKESEN KURTÇA, Ondokuz Mayıs University

ROLE OF DUAL-TASK COST IN PREDICTING FALL RISK IN OLDER ADULTS RECEIVING INSTITUTIONAL CARE: A CROSS-SECTIONAL CLASSIFICATION MODEL

There is a need for studies that examine the role of dual-task cost in predicting fall risk among older adults receiving institutional care and that develop classification models that can be used in clinical practice. The planned study aims to determine the discriminative ability of dual-task cost in identifying fall risk and to establish clinically meaningful cutoff values. In this respect, the study will both contribute to a more sensitive assessment of fall risk and provide a scientific basis for a low-cost, practical, and applicable screening approach.

Panoramica dello studio

Descrizione dettagliata

Changes in motor and cognitive functions that occur with the aging process negatively affect individuals' mobility and balance performance, there by increasing the risk of falls. Today, it is widely accepted that gait and postural control are not merely motor processes, but also require the active participation of attention and executive cognitive processes. In this context, the dual-task approach-wherein an individual simultaneously performs a second cognitive or motor task during gait-has become a widely utilized method for evaluating cognitive-motor interaction in older adults (Muir-Hunter & Wittwer, 2016). Performance degradation under dual-task conditions is explained by the individual having to allocate limited cognitive resources between two tasks, a phenomenon that becomes particularly more pronounced in older adults. Studies in the literature examining the relationship between dual-task performance and falls demonstrate that performance changes occurring under dual-task conditions are more strongly associated with falls compared to single-task conditions (Muir-Hunter & Wittwer, 2016). However, there is still no full consensus on which protocol, which secondary task, and which performance outcome are clinically most meaningful in dual-task assessments. The dual-task Timed Up and Go (TUG) test stands out as a practical and clinically applicable method for evaluating functional mobility. Tang et al. (2014) showed that motor dual-task TUG performance was superior to single-task TUG in discriminating the state of prefrailty in middle-aged and older adults. In the same study, it was reported that the ROC analysis of dual-task TUG performance showed significant discriminative power, and slow performance significantly increased the likelihood of prefrailty. These findings reveal that dual-task-based measurements are not only explanatory but also possess the potential to serve as classification tools and contribute to clinical decision-making processes. The relationship between cognitive functions and dual-task performance is another notable topic in the literature. It has been shown that both gait performance and cognitive performance deteriorate more markedly under dual-task conditions in individuals with mild cognitive impairment (Muir-Hunter & Wittwer, 2016). Furthermore, it is indicated that the type and difficulty level of the secondary task used have significant effects on dual-task performance. This situation highlights the critical importance of standardizing dual-task assessments. Fear of falling is also a major factor affecting functional performance in older adults. In a study conducted by Sapmaz et al. (2021) on institutionalized older adults, it was shown that individuals with a fear of falling had worse single-task and dual-task TUG performances; additionally, their balance and mobility levels were also lower. These findings demonstrate that the fear of falling is not merely a psychological condition but is closely related to functional capacity. However, a large part of current studies remains at the group-comparison level, and analyses modeling the role of dual-task performance in predicting clinical fall risk remain limited. Recent studies show that dual-task assessments are highly sensitive in uncovering hidden functional impairments in older adults (Falbo et al., 2016). Especially in frail populations such as institutionalized older adults, dual-task performance is thought to be closely associated with falls. However, most of these studies either feature intervention-based designs or are limited strictly to correlation analyses. A prominent gap in the literature is the scarcity of studies evaluating fall risk via dual-task cost (which represents the relative change compared to single-task performance) rather than absolute measurements of dual-task performance. Because dual-task cost reflects the relative deterioration in an individual's performance under cognitive load, it may serve as a clinically more meaningful indicator. Nevertheless, studies examining the role of dual-task cost in discriminating fall risk and establishing a cross-sectional classification model based on this variable remain highly limited.

Tipo di studio

Osservativo

Iscrizione (Stimato)

52

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto più anziano

Accetta volontari sani

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

The target population for this cross-sectional study consists of older adults residing in long-term care facilities and nursing homes. Participants will be selected based on the predefined inclusion criteria. These eligibility criteria are designed to ensure safety, cognitive comprehension, and physical compliance during the functional and dual-task assessments.

Descrizione

Inclusion Criteria:

  • Being 65 years of age or older
  • Residing in a nursing home or care institution for at least 1 month
  • Ability to walk a distance of at least 10 meters
  • Ability to ambulate independently with an assistive device (e.g., cane, walker), if needed
  • Having a Montreal Cognitive Assessment (MoCA) score of 18 or above
  • Ability to understand and execute single- and two-step verbal commands
  • Voluntary agreement to participate in the study and providing informed consent

Exclusion Criteria:

  • History of stroke or major orthopedic surgery within the past 6 monthsPresence of Parkinson's disease Stage ≥3 (Hoehn & Yahr) or any other neurological condition significantly affecting gait
  • Having a MoCA score below 18
  • History of fracture within the past 3 months
  • Presence of severe pain affecting gait during test administration (Visual Analog Scale [VAS] ≥ 7)
  • Uncontrolled hypertension (≥ 180/100 mmHg) or unstable cardiovascular status
  • Active vestibular disease or a history of syncope within the past 3 months
  • Visual or hearing impairment severe enough to impede test execution
  • Inability to walk/ambulate without the physical assistance of another person

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Clinical Information Form
Lasso di tempo: Single assessment (baseline)

The following participant information will be recorded using a clinical information form developed by the researcher:

Age (years)

Sex (male/female)

Educational status(illitirate/primare education/secondary education/high school or higher)

Length of institutional stay( months and years)

Height(cm)

Weight(kg)

Body mass index BMI (kg/m²)

Number of chronic diseases and comorbidities

Number of daily medications

Use of assistive devices

Single assessment (baseline)
Fall Assesment
Lasso di tempo: Single assessment (baseline)

Fall history (Tripping, Slipping, Loss of Balance, Transposition)

Fall History Questionnaire

A fall will be defined as an event which results in an individual coming to rest inadvertently on the ground, floor, or a lower level. In this context, the following information will be recorded:

Presence of a fall within the last 12 months (yes/no)

Total number of falls within the last 12 months

Presence of a fall within the last month (yes/no)

Primary cause of the last fall

Location of the last fall

Injury status resulting from the last fall

Single assessment (baseline)
Montreal Cognitive Assessment (MoCA)
Lasso di tempo: Single assessment (baseline)
This assessment will be utilized to determine whether participants possess the cognitive competence to understand and execute the study protocol. Individuals with a MoCA score below 18 will be excluded from the study.
Single assessment (baseline)
Timed Up and Go Test (TUG)
Lasso di tempo: Single assessment (baseline)
This test will be utilized to assess the functional mobility of the participants. The participant will be instructed to rise from a standard-height chair, walk a distance of 3 meters, turn around, return to the chair, and sit back down. The duration of the test will be recorded in seconds.
Single assessment (baseline)
Dual-task Timed Up and Go Test (TUG-DT)
Lasso di tempo: Single assessment (baseline)

This test will be administered to evaluate the dual-task performance of the participants. Participants will be instructed to simultaneously perform a cognitive task during the TUG test.

Cognitive Task Animal naming will be utilized as the cognitive task under the dual-task condition. The participant will be asked to name as many animals as possible while walking. All participants will be assigned the same task, and standard verbal instructions will be utilized.

Single assessment (baseline)
Dual-Task Cost (DTC)
Lasso di tempo: Single assessment (baseline)
The dual-task cost will be calculated using the single-task TUG and dual-task TUG durations according to the following formula: DTC (%)"=(TUG_DT-TUG)/TUG×100 An increase in the DTC percentage will indicate greater performance degradation under the dual-task condition.
Single assessment (baseline)
Tinetti Performance-Oriented Mobility Assessment (POMA)
Lasso di tempo: Single assessment (baseline)

This assessment will be utilized to evaluate the balance and gait performance of the participants. The total Tinetti score will be used to determine the risk of falls.

Operational Definition of Fall Risk

Fall risk will be operationalized in two ways in the study:

As a continuous variable: Total Tinetti score

As a binary classification variable: Risk group based on the Tinetti score

Classification based on the Tinetti score will be structured as follows:

Low fall risk: 25-28 points

Increased fall risk: 24 points and below

This binary classification will be utilized for the classification model and ROC analysis.

Single assessment (baseline)
Falls Efficacy Scale-International (FES-I)
Lasso di tempo: Single assessment (baseline)
This scale will be utilized to assess the participants' level of fear of falling as a descriptive and secondary variable. The FES-I score will not serve as a primary variable in the main model; however, it will be reported in descriptive analyses and secondary analyses as required.
Single assessment (baseline)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 giugno 2026

Completamento primario (Stimato)

1 novembre 2026

Completamento dello studio (Stimato)

1 novembre 2026

Date di iscrizione allo studio

Primo inviato

16 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

3 giugno 2026

Primo Inserito (Effettivo)

8 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

8 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

3 giugno 2026

Ultimo verificato

1 giugno 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 2026/276

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi